These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
237 related articles for article (PubMed ID: 32568566)
1. The diagnostic role and clinical association of serum proteinase 3 anti-neutrophil cytoplasmic antibodies in Chinese patients with inflammatory bowel disease. Xu Y; Xu F; Li W; Li M; Dong S; Zhang Y; Norman GL; Zhao Q; Liu L Scand J Gastroenterol; 2020 Jul; 55(7):806-813. PubMed ID: 32568566 [No Abstract] [Full Text] [Related]
2. PR3-ANCA and panel diagnostics in pediatric inflammatory bowel disease to distinguish ulcerative colitis from Crohn's disease. Horn MP; Peter AM; Righini Grunder F; Leichtle AB; Spalinger J; Schibli S; Sokollik C PLoS One; 2018; 13(12):e0208974. PubMed ID: 30557305 [TBL] [Abstract][Full Text] [Related]
3. PR3-ANCA: a promising biomarker for ulcerative colitis with extensive disease. Mahler M; Bogdanos DP; Pavlidis P; Fritzler MJ; Csernok E; Damoiseaux J; Bentow C; Shums Z; Forbes A; Norman GL Clin Chim Acta; 2013 Sep; 424():267-73. PubMed ID: 23806819 [TBL] [Abstract][Full Text] [Related]
4. Presence of anti-proteinase 3 antineutrophil cytoplasmic antibodies (anti-PR3 ANCA) as serologic markers in inflammatory bowel disease. Arias-Loste MT; Bonilla G; Moraleja I; Mahler M; Mieses MA; Castro B; Rivero M; Crespo J; López-Hoyos M Clin Rev Allergy Immunol; 2013 Aug; 45(1):109-16. PubMed ID: 23345025 [TBL] [Abstract][Full Text] [Related]
11. Anti-neutrophil cytoplasmic antibodies (ANCA) specific for one or several antigens: useful markers for subtypes of ulcerative colitis and associated primary sclerosing cholangitis. Dobric S; Popovic D; Nikolic M; Andrejevic S; Spuran M; Bonaci-Nikolic B Clin Chem Lab Med; 2011 Nov; 50(3):503-9. PubMed ID: 22107137 [TBL] [Abstract][Full Text] [Related]